DARUNAVIR TECHNOLOGY TRANSFER PROJECT APPROVED IN BRAZILThe Brazilian Inter-Ministerial Group (GECIS) approved a US$ 140 million technology transfer project for Darunavir in favour of NTPharm, the Brazilian partner of Belgium-based VAYA Pharmaceuticals, in its executive meeting held in Sao Paulo on April 11, 2013. The technology transfer project is based on a government plan referred to as PDP (Production Development Project), designed to promote local production of pharmaceuticals products.According to Ashish Sehgal, Managing Director of VAYA Pharmaceuticals, the Brazilian government is actively pursuing an agenda for locally manufactured products and a strategy focussed on bringing in new technologies. This evolving market scenario has the potential to bring in numerous business opportunities for Indian generic players. Brazil is currently the 6th largest pharmaceutical market in the world, growing at an annual rate of 23%. VAYA Pharmaceuticals offers professional business development consulting and implementation services for the markets of Europe and Brazil.Ashish SehgalVAYA PharmaceuticalsBelgiumMobile: +32 – 492 – 702441Skype: vayabelgiumWebsite: www.vayapharmaceuticals.com